TotalMarketCap

Tempest Therapeutics

TPSTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.506 M

$0.38 -18.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Tempest Therapeutics (TPST) has a market capitalization of $7.51M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.3M

Loss-making

Shares outstanding

14,344,034

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #426Lantern PharmaLTRN$8.09M
  2. #427Alaunos TherapeuticsTCRT$7.51M
  3. #428Tempest TherapeuticsTPST$7.51M
  4. #429Theriva BiologicsTOVX$7.43M
  5. #430Alzamend NeuroALZN$7.38M

What if Tempest Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,412,172

Per share 3,761,778× higher

Bitcoin $1.53T

$76,410.14

Per share 203,543× higher

Apple $5.02T

$250,847.37

Per share 668,214× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Tempest Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.